It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...

Updated with news that Google is cracking down on non-compliant senders ahead of the holidays. The post Bulk email restrictions from Google, Yahoo and Microsoft: What you need to know appeared first ...